申请人:Merck Sharp & Dohme Limited
公开号:US07592456B2
公开(公告)日:2009-09-22
Compounds of formula (I) are potent and selective 5-HT2A antagonists, useful in treatment of a variety of adverse conditions of the CNS.
公式(I)的化合物是有效且选择性的5-HT2A拮抗剂,在治疗中枢神经系统的各种不良症状方面非常有用。